Clinical Trial: Study on a Pan-cancer Multidimensional Immune Efficacy Prediction and Early Warning Model Integrating the "Treating Different Diseases with the Same Method" Theory of Traditional Chinese Medicine and Artificial Intelligence (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on a Pan-cancer Multidimensional Immune Efficacy Prediction and Early Warning Model Integrating the "Treating Different Diseases with the Same Method" Theory of Traditional Chinese Medicine and Artificial Intelligence'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132990

Registration Time: 2026/09/20

Type: Observational study

Primary Sponsor: Sichuan Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344463

Published by HT Digital Content Services with permission from Health Daily Digest....